573 related articles for article (PubMed ID: 8033140)
1. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
Berger SJ; Gosky D; Zborowska E; Willson JK; Berger NA
Cancer Res; 1994 Aug; 54(15):4077-83. PubMed ID: 8033140
[TBL] [Abstract][Full Text] [Related]
2. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice.
Skapek SX; Colvin OM; Griffith OW; Elion GB; Bigner DD; Friedman HS
Cancer Res; 1988 May; 48(10):2764-7. PubMed ID: 3359437
[TBL] [Abstract][Full Text] [Related]
3. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
Kramer RA; Greene K; Ahmad S; Vistica DT
Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
[TBL] [Abstract][Full Text] [Related]
4. Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts.
Guichard M; Lespinasse F; Malaise EP
Radiat Res; 1986 Jan; 105(1):115-25. PubMed ID: 3945723
[TBL] [Abstract][Full Text] [Related]
5. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
Xu BH; Gupta V; Singh SV
Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
[TBL] [Abstract][Full Text] [Related]
6. [Increasing chemosensitivity to cisplatin by glutathione depletion with buthionine sulfoximine. In vitro and in vivo studies with a human squamous cell cancer line].
Bier H
Laryngorhinootologie; 1990 Jan; 69(1):16-20. PubMed ID: 2310456
[TBL] [Abstract][Full Text] [Related]
7. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
[TBL] [Abstract][Full Text] [Related]
8. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.
Yao K; Godwin AK; Ozols RF; Hamilton TC; O'Dwyer PJ
Cancer Res; 1993 Aug; 53(16):3662-6. PubMed ID: 8101766
[TBL] [Abstract][Full Text] [Related]
9. Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro.
Perry RR; Greaves BR; Rasberry U; Barranco SC
Cancer Res; 1992 Sep; 52(17):4608-12. PubMed ID: 1511428
[TBL] [Abstract][Full Text] [Related]
10. Glutathione depletion in rested and exercised mice: biochemical consequence and adaptation.
Leeuwenburgh C; Ji LL
Arch Biochem Biophys; 1995 Feb; 316(2):941-9. PubMed ID: 7864653
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide resistance in medulloblastoma.
Friedman HS; Colvin OM; Kaufmann SH; Ludeman SM; Bullock N; Bigner DD; Griffith OW
Cancer Res; 1992 Oct; 52(19):5373-8. PubMed ID: 1356617
[TBL] [Abstract][Full Text] [Related]
12. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT
Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834
[TBL] [Abstract][Full Text] [Related]
13. Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.
Armstrong DK; Gordon GB; Hilton J; Streeper RT; Colvin OM; Davidson NE
Cancer Res; 1992 Mar; 52(6):1416-21. PubMed ID: 1540950
[TBL] [Abstract][Full Text] [Related]
14. gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver.
Obrador E; Carretero J; Ortega A; Medina I; Rodilla V; Pellicer JA; Estrela JM
Hepatology; 2002 Jan; 35(1):74-81. PubMed ID: 11786961
[TBL] [Abstract][Full Text] [Related]
15. Comparison of glutathione levels in rodent and human tumor cells grown in vitro and in vivo.
Allalunis-Turner MJ; Lee FY; Siemann DW
Cancer Res; 1988 Jul; 48(13):3657-60. PubMed ID: 3378208
[TBL] [Abstract][Full Text] [Related]
16. On the metallothionein, glutathione and cysteine relationship in rat liver.
Hidalgo J; Garvey JS; Armario A
J Pharmacol Exp Ther; 1990 Nov; 255(2):554-64. PubMed ID: 2243342
[TBL] [Abstract][Full Text] [Related]
17. Glutathione contents in human and rodent tumor cells in various phases of the cell cycle.
Lee FY; Siemann DW; Allalunis-Turner MJ; Keng PC
Cancer Res; 1988 Jul; 48(13):3661-5. PubMed ID: 3378209
[TBL] [Abstract][Full Text] [Related]
18. Glutathione redox cycle-driven recovery of reduced glutathione after oxidation by tertiary-butyl hydroperoxide in preimplantation mouse embryos.
Gardiner CS; Reed DJ
Arch Biochem Biophys; 1995 Aug; 321(1):6-12. PubMed ID: 7639536
[TBL] [Abstract][Full Text] [Related]
19. Long-term buthionine-sulfoximine-mediated toxicity in cultured hepatoma cell lines.
Dierickx PJ
Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):423-6. PubMed ID: 2160706
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of glutathione content in human ovarian cancer.
Lee FY; Vessey A; Rofstad E; Siemann DW; Sutherland RM
Cancer Res; 1989 Oct; 49(19):5244-8. PubMed ID: 2766292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]